UNICA IRIS Institutional Research Information System

BALBONI, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 156.141
NA - Nord America 16.118
AS - Asia 5.805
SA - Sud America 941
Continente sconosciuto - Info sul continente non disponibili 596
AF - Africa 137
OC - Oceania 25
Totale 179.763
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 152.734
US - Stati Uniti d'America 15.839
SG - Singapore 2.299
CN - Cina 1.886
UA - Ucraina 981
BR - Brasile 731
SE - Svezia 672
VN - Vietnam 494
GB - Regno Unito 441
FI - Finlandia 405
DE - Germania 307
FR - Francia 307
HK - Hong Kong 297
IN - India 197
CA - Canada 152
KR - Corea 125
BD - Bangladesh 95
RU - Federazione Russa 76
AR - Argentina 73
IQ - Iraq 51
MX - Messico 46
JP - Giappone 40
NL - Olanda 38
ID - Indonesia 37
PK - Pakistan 34
VE - Venezuela 34
CO - Colombia 33
ES - Italia 33
MA - Marocco 31
EC - Ecuador 29
TR - Turchia 29
AT - Austria 26
BE - Belgio 24
ZA - Sudafrica 22
UZ - Uzbekistan 21
AU - Australia 20
JM - Giamaica 20
PH - Filippine 20
PL - Polonia 20
SA - Arabia Saudita 20
KH - Cambogia 19
IL - Israele 18
CL - Cile 16
JO - Giordania 15
NP - Nepal 14
KE - Kenya 13
KZ - Kazakistan 13
CR - Costa Rica 12
EG - Egitto 12
IE - Irlanda 12
MU - Mauritius 12
MY - Malesia 12
TN - Tunisia 11
DZ - Algeria 10
PE - Perù 10
TT - Trinidad e Tobago 10
AZ - Azerbaigian 9
CH - Svizzera 9
GT - Guatemala 9
AE - Emirati Arabi Uniti 8
LB - Libano 8
PY - Paraguay 8
TH - Thailandia 8
HN - Honduras 7
LT - Lituania 7
DO - Repubblica Dominicana 6
HU - Ungheria 6
NG - Nigeria 6
EE - Estonia 5
PS - Palestinian Territory 5
SN - Senegal 5
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
RS - Serbia 4
TW - Taiwan 4
BB - Barbados 3
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
CW - ???statistics.table.value.countryCode.CW??? 2
GR - Grecia 2
IR - Iran 2
Totale 179.139
Salva come PNG Salva come JPEG
Città #
Cagliari 146.165
Uta 5.881
Ashburn 1.685
Fairfield 1.226
Singapore 1.183
Houston 1.045
Woodbridge 1.039
Chandler 978
San Jose 958
Boardman 750
Dallas 680
Ann Arbor 538
Wilmington 525
Jacksonville 524
Seattle 506
Cambridge 465
Nyköping 353
Council Bluffs 346
Los Angeles 287
Beijing 269
Hong Kong 250
Hefei 232
Helsinki 231
Santa Clara 196
Nanjing 187
Boston 183
Lauterbourg 168
The Dalles 163
Dearborn 132
Ho Chi Minh City 131
Buffalo 128
Seoul 117
Hanoi 108
San Diego 105
Milan 102
Columbus 96
Shanghai 92
New York 80
São Paulo 73
Dong Ket 66
Nanchang 57
Rome 57
Mountain View 56
Shenyang 56
Toronto 55
Chicago 53
Verona 53
Redwood City 52
London 50
Jiaxing 49
Tianjin 49
Ferrara 46
Guangzhou 46
Washington 45
Phoenix 42
Changsha 40
Frankfurt am Main 40
Pune 40
Hebei 38
Falls Church 35
Norwalk 35
Brooklyn 31
Paris 28
Sassari 28
Tokyo 28
Atlanta 27
Jinan 26
Orange 26
Orem 26
San Francisco 25
Redondo Beach 24
Ningbo 21
Saint Petersburg 21
Belo Horizonte 20
Mexico City 20
Tashkent 20
Baghdad 19
Naples 19
Nuremberg 19
Phnom Penh 19
Rio de Janeiro 19
Haiphong 17
Olbia 17
Brussels 16
Munich 16
North Bergen 16
Canberra 15
Denver 15
Zhengzhou 15
Amman 14
Casablanca 14
Jakarta 14
Montreal 14
Chennai 13
Hyderabad 13
Lahore 13
Miami 13
Tappahannock 13
Warsaw 13
Auburn Hills 12
Totale 169.976
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and evaluation of antiproliferative activity of new benzimidazolehydrazones 2.934
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.885
Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors 2.863
Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain 2.822
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.749
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.728
TRPV1 modulators: synthesis and in vitro evaluation of 1-heteroarylpiperidinecarboxamide and piperazinylurea derivatives 2.685
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.612
DIHYDROQUINAZOLINE BENZYLAMIDES AS ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITORS 2.609
DESIGN, SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NEW DNA METHYLTRANSFERASE INHIBITORS 2.598
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives 2.543
Attenuating Ischemic Disruption of K+ Homeostasis in the Cortex of Hypoxic-Ischemic Neonatal Rats: DOR Activation vs. Acupuncture Treatment 2.489
Critical role for prokineticin 2 in CNS autoimmunity 2.485
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.397
3,4-Dihydroquinazoline derivatives inhibit the activities of cholinesterase enzymes 2.331
Benzofuran hydrazones as potential scaffold in the development of multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity 2.302
Indole derivatives as multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indole hydrazones 2.288
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.261
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation 2.249
Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy 2.231
Antagonism of EG-VEGF receptors as targeted therapy for choriocarcinoma progression in vitro and in vivo 2.118
Synthesis and evaluation of antioxidant and antiproliferative activity of 2-arylbenzimidazoles 2.096
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy 2.085
Synthesis and SIRT1 modulation studies of amides and hydrazides of benzoic acid incorporating a (2-trifluoromethylpyridin-4-yl)amino moiety 2.060
In-Vitro Evaluation of Antioxidant, Antiproliferative and Photo-Protective Activities of Benzimidazolehydrazone Derivatives 2.023
Interaction and reactivity of synthetic aminoisoflavones with metal-free and metalassociated amyloid-beta 1.922
PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice 1.881
An important role for prokineticin 2 in autoimmune CNS demyelination 1.830
Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors 1.801
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties 1.800
null 1.768
δ-Opioid Receptor Activation Attenuates Hypoxia/MPP+-Induced Downregulation of PINK1: a Novel Mechanism of Neuroprotection Against Parkinsonian Injury 1.667
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 1.654
Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease 1.596
Genetically Encodable Bacterial Flavin Transferase for Fluorogenic Protein Modification in Mammalian Cells 1.596
Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated 1.566
Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors 1.558
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity 1.491
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 1.467
Prokineticin 2 promotes and sustains neuroinflammation in vincristine treated mice: Focus on pain and emotional like behavior 1.417
null 1.383
Antagonism of EG-VEGF receptors is a novel targeted therapy for choriocarcinoma progression: in vitro, in vivo and in clinical studies 1.381
Ligand- and cell-dependent determinants and cAMP modulation by delta opioid receptor (DOR) agonists 1.366
A novel mechanism for cytoprotection against hypoxic injury: delta-opioid receptor-mediated increase in Nrf2 translocation 1.363
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins 1.359
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors 1.347
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system 1.294
The antagonism of the prokineticin system counteracts bortezomib induced side effects: Focus on mood alterations 1.291
Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes 1.275
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context 1.259
Prokineticin 1-prokineticin receptor 1 signaling promotes angiogenesis in the porcine endometrium during pregnancy 1.180
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain 1.178
∂-opioid receptor activation protects against Parkinson’s disease-related mitochondrial dysfunction by enhancing PINK1/Parkin-dependent mitophagy 1.167
Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals 1.106
Opposite Roles of δ- and μ-Opioid Receptors in BACE1 Regulation and Alzheimer’s Injury 1.100
Evidence-Based View of Safety and Effectiveness of Prokineticin Receptors Antagonists during Pregnancy 1.060
Antidepressant-like and anxiolytic-like effects following activation of the mu-delta opioid receptor heteromer in the nucleus accumbens 961
Synthesis and Carbonic Anhydrase Inhibitory Activity of New 2-Aminochromenone Derivatives 915
activation of the mu-delta opioid receptor heteromer produces anti-depressant-like and anxiolytic-like effects 891
δ‐Opioid receptors up‐regulate excitatory amino acid transporters in mouse astrocytes 888
Delta-opioid receptor activation modified microRNA expression in the rat kidney under prolonged hypoxia 881
Effect of delta-opioid receptor activation on BDNF-TrkB vs. TNF-Alpha in the mouse cortex exposed to prolonged hypoxia 870
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 857
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 844
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain 838
New features of the delta opioid receptor: conformationalproperties of deltorphin I analogues 828
Hair Growth Promotion by δ-Opioid Receptor Activation 827
null 825
Agonists at the delta-opioid receptor modify the binding of mu-receptor agonists to the mu-delta receptor hetero-oligomer 824
Prokineticin receptors antagonist PC-10 as a biomarker for imaging inflammatory pain 823
Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis 751
Blocking prokineticin receptors attenuates synovitis and joint destruction in collagen-induced arthritis 750
Conformational dynamics of KIR3.1/KIR3.2 channel activation via delta-opioid receptors (DORs) 741
Structural and biological exploration of Phe3-Phe4-modified endomorphin-2 peptidomimetics 738
Ligands raise the constraint that limits constitutive activation in G protein-coupled opioid receptors 735
null 731
Hydrogen sulfide inhibits inflammatory pain and enhances the analgesic properties of delta opioid receptors 720
Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity 700
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues. 696
DOR activation inhibits anoxic/ischemic Na+ influx through Na+ channels via PKC mechanisms in the cortex 691
Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore 669
Na+ mechanism of delta-opioid receptor induced protection from K+ leakage in the cortex 660
Prokineticin System Is a Pharmacological Target to Counteract Pain and Its Comorbid Mood Alterations in an Osteoarthritis Murine Model 651
Role of the 2',6'-dimethyl-L-tyrosine (Dmt) in some opioid lead compounds 646
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues 643
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist, correlation between desensitization and tolerance 642
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 637
Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors 629
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain 617
Structure-activity relatioships of tetrapeptides related to dermorphin: a 500-MHz 1H-nmr study 598
A Critical Role of δ-Opioid Receptor in Anti-microglial Activation Under Stress 594
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore 578
Hydrogen Sulfide Increases the Analgesic Effects of µ- and δ-Opioid Receptors during Neuropathic Pain: Pathways Implicated 571
Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice 568
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 568
Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism 557
Opioid peptides. Synthesis and binding properties of dermorphin related heptapeptides 548
null 546
Opioid deltorphin C analogues containing cis- or-trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues 545
Prokineticin 1 is a novel factor regulating porcine corpus luteum function 541
Totale 137.899
Salva come PNG Salva come JPEG
Categoria #
all - tutte 268.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 268.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.048 0 0 0 529 420 819 912 643 595 587 934 1.609
2022/202316.522 1.658 1.741 1.164 1.262 1.464 2.157 1.168 1.527 978 1.019 1.601 783
2023/202419.214 725 818 712 1.288 1.898 3.050 3.230 1.222 924 1.297 1.763 2.287
2024/202539.798 8.850 11.727 5.060 4.256 2.362 2.242 3.438 216 421 314 361 551
2025/202610.356 606 578 1.421 759 666 648 1.493 818 936 1.656 629 146
2026/20272.637 360 460 830 987 0 0 0 0 0 0 0 0
Totale 179.763